VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PALI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PALIPalisade Bio, Inc.
$2.08$436M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPALIQuarterly Financials

Palisade Bio, Inc. (PALI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Palisade Bio, Inc. (PALI) quarterly income statement — complete revenue, gross profit & net income history

PALI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000000250K0000000
Revenue Growth %---------100%-----------100%
Cost of Goods Sold000000001K00000000000
COGS % of Revenue--------------------
Gross Profit00000000-1K000250K0000000
Gross Margin %------------100%-------
Gross Profit Growth %----100%----100.4%---------100%-100%
Operating Expenses10.75M9.98M2.92M2.84M2.31M3.38M3.59M4.21M3.67M3.15M3.78M3.61M2.78M3.85M4.41M3.57M3.89M4.03M3.02M32.86M
OpEx % of Revenue------------1111.6%-------
Selling, General & Admin4.35M3.81M1.53M1.17M1.36M1.3M1.46M1.58M1.46M1.56M1.67M1.43M1.54M1.5M2.08M2.25M2.93M3.23M2.39M2.43M
SG&A % of Revenue------------615.2%-------
Research & Development6.4M6.17M1.39M1.68M950K2.08M2.14M2.63M2.21M1.37M2.1M2.18M1.24M2.34M1.93M1.32M959K800K624K314K
R&D % of Revenue------------496.4%-------
Other Operating Expenses000000000225K0000410K00001000K
Operating Income-10.75M-9.98M-2.92M-2.84M-2.31M-3.38M-3.59M-4.21M-3.67M-3.15M-3.78M-3.61M-2.53M-3.85M-4.41M-3.57M-3.89M-4.03M-3.02M-32.86M
Operating Margin %-------------1011.6%-------
Operating Income Growth %-365.28%-195.12%18.68%32.49%37.11%-7.23%4.9%-16.68%-45.24%18.04%14.39%-1.04%34.95%4.45%-46.32%89.13%-98.98%-24.1%-66.08%-1684.79%
EBITDA-10.75M-9.98M-2.92M-2.84M-2.31M-3.38M-3.59M-4.21M-3.67M-2.93M-3.78M-3.61M-2.53M-3.85M-3.99M-2.34M-3.89M-4.03M8.11M-32.86M
EBITDA Margin %-------------1011.2%-------
EBITDA Growth %-365.48%-195.21%18.68%32.49%37.12%-15.47%4.9%-16.72%-45.25%23.84%5.27%-54.21%34.96%4.49%-149.14%92.88%-99.03%-24.14%573.61%-1685.22%
D&A (Non-Cash Add-back)0-3K1K1K1K01K1K1K01K2K1K2K001K001K
EBIT-10.75M-10.18M-2.86M-2.78M-2.23M-3.38M-3.48M-4.08M-3.53M-2.93M-3.59M-3.39M-2.34M-3.85M-3.99M-2.34M-4.2M-4.03M8.11M-31.09M
Net Interest Income1K-2K-5K-2K-1K-3K-6K-2K-1K-4K-8K-3K0-3K-4K-5K-1K-5K-26K-655K
Interest Income00000000000000000000
Interest Expense-1K2K5K2K1K3K6K2K1K4K8K3K03K4K5K1K5K26K655K
Other Income/Expense1.15M1.08M54K59K80K38K106K131K146K183K182K216K189K128K422K1.23M-317K5.1M11.1M1.11M
Pretax Income-9.6M-8.9M-2.87M-2.78M-2.23M-3.34M-3.49M-4.08M-3.53M-2.97M-3.6M-3.39M-2.34M-3.72M-3.99M-2.34M-4.21M1.07M8.09M-31.75M
Pretax Margin %-------------936%-------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-9.6M-8.9M-2.87M-2.78M-2.23M-3.34M-3.49M-4.08M-3.53M-2.97M-3.6M-3.39M-2.34M-3.72M-3.99M-2.34M-4.21M1.07M8.09M-31.75M
Net Margin %-------------936%-------
Net Income Growth %-330.49%-166.12%17.75%31.76%36.77%-12.55%3.03%-20.25%-50.73%20.13%9.9%-44.75%44.35%-446.69%-149.35%92.62%-4.34%125.28%538.8%-1615.07%
Net Income (Continuing)-9.6M-8.9M-2.87M-2.78M-2.23M-3.34M-3.49M-4.08M-3.53M-2.97M-3.6M-3.39M-2.34M-3.72M-3.99M-2.34M-4.21M1.07M8.09M-31.75M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.05-0.06-0.38-0.58-0.46-0.39-2.32-3.32-4.59-0.32-7.38-7.93-8.13-1.49-61.50-2.75-13.943.9633.40-3075.00
EPS Growth %90.04%85.69%83.62%82.53%89.98%-21.88%68.56%58.13%43.54%78.52%88%-188.36%41.68%-137.63%-284.13%99.91%17.9%122.15%530.41%-39323.08%
EPS (Basic)-0.05-0.06-0.38-0.58-0.46-0.57-2.32-3.32-4.59-0.51-7.38-7.93-8.13-1.49-61.50-86.55-194.403.96315.00-2692.50
Diluted Shares Outstanding209.66M55.67M7.47M4.8M4.8M8.54M5.82M5.82M12.63M9.27M489.62K427.86K287.7K1.8M64.95K405.9K324.48K270.66K242.13K11.98K
Basic Shares Outstanding209.66M55.67M7.47M4.8M4.8M5.82M5.82M5.82M768.14K5.82M489.62K6.4M4.32M1.8M64.95K405.9K324.45K270.66K16.13K11.78K
Dividend Payout Ratio--------------------